4DMedical Limited (FDMDF) Financier

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. Leveraging its proprietary XV Technology and Imbio Technology, the Company provides cutting-edge thoracic imaging that enhances physician diagnoses and management of respiratory conditions. XV technology delivers detailed insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. The company produces software and hardware products that enable new levels of non-invasive, quantitative analysis of lung function. Its products include CAC (Coronary Artery Calcification), CT-LVAS (Computed Tomography Lung Ventilation Analysis Software), IQ-UIP, LDAf (Functional Lung Density Analysis), LDAi (Lung Density Analysis-Inspiration), LTA (Lung Texture Analysis), PHA Analysis (Pulmonary Hypertension Assessment), XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software), and XV Scanner.